Operose Advisors LLC
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1909750
MILWAUKEE, WI
Position in TEVA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$68,979
+$7,655 QoQ
Shares Held
2,036
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#529
of 671 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Operose Advisors LLC holds $123,376 across 3 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (55.9% of the industry book) .
All Filings in TEVA
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $68,979 | 2,036 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $61,324 | 2,036 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $63,543 | 2,036 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $41,127 | 2,036 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $34,123 | 2,036 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $31,293 | 2,036 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $44,873 | 2,036 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $36,688 | 2,036 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $33,085 | 2,036 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $28,727 | 2,036 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $21,255 | 2,036 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $20,767 | 2,036 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $15,331 | 2,036 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $18,018 | 2,036 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $18,568 | 2,036 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $16,140 | 2,000 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||